Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with a suboptimal response to previous disease-modifying therapies (1‑year interim results)

Saved in:
Bibliographic Details
Published in:Journal of the neurological sciences Vol. 405; p. 310
Main Authors: Vermersch, P., Eralinna, J.P., Nicholas, R., Oreja-Guevara, C., Siva, A., Van Wijmeersch, B., Wiendl, H., Buffels, R., Kuhelj, R., Wei, W., Comi, G.
Format: Journal Article
Language:English
Published: Elsevier B.V 15.10.2019
Subjects:
ISSN:0022-510X, 1878-5883
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0022-510X
1878-5883
DOI:10.1016/j.jns.2019.10.1404